Sanofi SA:企業のM&A・事業提携・投資動向

◆英語タイトル:Sanofi SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2118
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:141
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Sanofi SA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Sanofi SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Sanofi SA since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Sanofi SA’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Sanofi SA. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Sanofi SA’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Sanofi SA and its subsidiaries since 2007.
- Information about key financial and legal advisors for Sanofi SA’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Sanofi SA’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 20
Corporate Venturing – Overview 20
Corporate Venturing – Deal reports 21
PARTNERSHIP 24
Partnership – Overview 24
Partnership – Deal reports 25
CAPITAL RAISING 97
Capital Raising – Overview 97
Capital Raising – Deal reports 98
DIVESTMENTS 114
Divestments – Overview 114
Divestments – Deal reports 115
APPENDIX 131
Contact Us 131
About MarketLine Financial Deals Database 131
Deal Definition and Methodology 133
About MarketLine 140

List of Tables
Table 1: Sanofi M&A volume and value trend (2014-YTD2018)
Table 2: Sanofi M&A activity by geography (2014-YTD2018)
Table 3: Sanofi corporate venturing volume and value trend (2014-YTD2018)
Table 4: Sanofi corporate venturing by geography (2014-YTD2018)
Table 5: Sanofi partnership volume and value trend (2014-YTD2018)
Table 6: Sanofi partnership trend by key deal type (2014-YTD2018)
Table 7: Sanofi capital raising volume and value trend (2014-YTD2018)
Table 8: Sanofi capital raising by deal type (2014-YTD2018)
Table 9: Sanofi divestments volume and value trend (2014-YTD2018)
Table 10: Sanofi divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Sanofi M&A volume and value trend (2014-YTD2018)
Figure 2: Sanofi M&A activity by geography (2014-YTD2018)
Figure 3: Sanofi corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Sanofi corporate venturing by geography (2014-YTD2018)
Figure 5: Sanofi partnership volume and value trend (2014-YTD2018)
Figure 6: Sanofi partnership trend by key deal type (2014-YTD2018)
Figure 7: Sanofi capital raising volume and value trend (2014-YTD2018)
Figure 8: Sanofi capital raising by deal type (2014-YTD2018)
Figure 9: Sanofi divestments volume and value trend (2014-YTD2018)
Figure 10: Sanofi divestments by geography (2014-YTD2018)

★海外企業調査レポート[Sanofi SA:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vitrolife AB (VITR):企業の財務・戦略的SWOT分析
    Summary Vitrolife AB (Vitrolife) is a developer, producer and marketer of laboratory products. The company provides products such as Oocyte retrieval needles, sperm processing, culture media, culture oil, additional culture media, micromanipulation solutions, vitrolife labware, micromanipulation pip …
  • Addnode Group AB (ANOD B):企業の財務・戦略的SWOT分析
    Summary Addnode Group AB (Addnode) is an information technology company that supplies software and services for construction, design, and product data information. The company's solutions include design management solutions, process management solutions, and product lifecycle management solutions, a …
  • KARL STORZ SE & Co KG:企業の戦略的SWOT分析
    KARL STORZ SE & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Culture Landmark Investment Ltd
    Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report Summary Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Red Electrica Corporacion, SA (REE):電力:M&Aディール及び事業提携情報
    Summary Red Electrica Corporacion, SA (REC), together with its subsidiaries undertakes electricity transmission and system operation and management of the transmission network for the Spanish electricity system. The company carries out the regulated activities through its principal subsidiary, Red E …
  • Alfred E. Tiefenbacher GmbH & Co KG:製薬・医療:M&Aディール及び事業提携情報
    Summary Alfred E. Tiefenbacher GmbH & Co KG (AET) is an independent pharmaceutical company that focuses on the development of active pharmaceuticals ingredients. It offers products in the forms of tablets, capsules, oral solution, patches, long acting injectables, ophthalmic solution and inhaled the …
  • Mapletree Investments Pte Ltd:企業の戦略的SWOT分析
    Mapletree Investments Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Starpharma Holdings Ltd (SPL):医療機器:M&Aディール及び事業提携情報
    Summary Starpharma Holdings Ltd (Starpharma) is a biotechnology company, which researches, develops and manufactures dendrimer products for pharmaceutical, life sciences and other applications. Dendrimers are synthetic nanoscale polymers with pharmaceutical and medical uses. The company’s developmen …
  • Christian Dior SE:企業の戦略・SWOT・財務情報
    Christian Dior SE - Strategy, SWOT and Corporate Finance Report Summary Christian Dior SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Hurtigruten AS:企業の戦略・SWOT・財務分析
    Hurtigruten AS - Strategy, SWOT and Corporate Finance Report Summary Hurtigruten AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Quaterra Resources Inc (QTA):企業の財務・戦略的SWOT分析
    Summary Quaterra Resources Inc (Quaterra Resources) is a copper exploration company that acquires and operates copper projects. The company's activities include acquisition, exploration and development of gold, silver, and copper deposits in Canada. Its projects comprise Quaterra’s Yerington Copper …
  • Analyticon Biotechnologies AG:企業の製品パイプライン分析2018
    Summary Analyticon Biotechnologies AG (Analyticon), a subsidiary of Analyticon Discovery GmbH, is a medical device company that develops, manufactures, and distributes diagnostic systems. The company provides products in the areas of urine diagnostics, clinical chemistry, coagulation, and hematology …
  • OJSC Rosneft Oil Company:企業の戦略・SWOT・財務分析
    OJSC Rosneft Oil Company - Strategy, SWOT and Corporate Finance Report Summary OJSC Rosneft Oil Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Alzheimer’s Drug Discovery Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Alzheimer's Drug Discovery Foundation (ADDF), formerly Institute for the Study of Aging is a drug discovery foundation. The foundation offers funds for drug discovery and development research programs in the field of Alzheimer’s disease, related dementias and cognitive aging. It offers servi …
  • Acer Inc (2353):企業の財務・戦略的SWOT分析
    Acer Inc (2353) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • VINCI Energies:企業のM&A・事業提携・投資動向
    VINCI Energies - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's VINCI Energies Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Core-Mark Holding Company, Inc. (CORE):企業の財務・戦略的SWOT分析
    Core-Mark Holding Company, Inc. (CORE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • The Hong Kong and China Gas Co Ltd (3):石油・ガス:M&Aディール及び事業提携情報
    Summary The Hong Kong and China Gas Company Limited (Towngas) is an energy company that produces distributes and markets the gas, water and related activities in Hong Kong and China. The company also carries out the LPG filling stations and utilization of landfill gas. The company has interests in v …
  • BioMedomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioMedomics Inc (BioMedomics) is a point-of-care diagnostics company that develops and markets immunologically-based disease-specific tests and advanced highly sensitive quantitative platforms. The company provides technologies such as time-resolved lateral flow immunoassay and nanotube base …
  • Unilever Pakistan Limited:企業の戦略・SWOT・財務情報
    Unilever Pakistan Limited - Strategy, SWOT and Corporate Finance Report Summary Unilever Pakistan Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆